https://www.ambergen.com/wp-content/uploads/logo-retina.png00Kenneth Rothschildhttps://www.ambergen.com/wp-content/uploads/logo-retina.pngKenneth Rothschild2014-10-27 13:38:252016-11-10 12:44:44AmberGen and Massachusetts General Hospital (MGH) are awarded US Patent 8,852,956 for two new diagnostic autoantigen biomarkers for the autoimmune liver disease Primary Biliary Cirrhosis (PBC)
